Higher Degree by Research Candidate
School of Biomedicine
Faculty of Health and Medical Sciences
Olivia is a PhD candidate in the school of Biomedicine and member of the Cognition, Ageing and Neurodegenerative Diseases Laboratory (CANDL) and the Animal Welfare and Cognitive Affective Neuroscience Laboratory (AWCAN). Her research focuses on understanding the role of neuroinflammation in chemotherapy-induced cognitive impairment and finding therapeutic strategies to improve quality of life for people suffering with this condition.
Olivia is also a practical demonstrator and tutor within the school of biomedicine, focusing on teaching the basics of neuroscience and neuroanatomy and within the school of animal sciences, focusing on laboratory animal skills.
Exploring the cognitive effects of chemotherapy-induced cognitive impairment
Understanding the role of neuroinflammation in chemotherapy-induced cognitive impairment
Date Institution name Country Title 2021 University of Adelaide Australia PhD in Biomedicine 2020 - 2020 University of Adelaide Australia Bachelor of Health and Medical Sciences (Honours) (First Class) 2016 - 2018 University of Adelaide Australia Bachelor of Health and Medical Sciences (Advanced)
Year Citation 2023 Haller, O. J., Semendric, I., George, R. P., Collins-Praino, L. E., & Whittaker, A. L. (2023). The effectiveness of anti-inflammatory agents in reducing chemotherapy-induced cognitive impairment in preclinical models – a systematic review. Neuroscience & Biobehavioral Reviews, 148, 105120-1-105120-37.
2023 Semendric, I., Pollock, D., Haller, O. J., George, R. P., Collins-Praino, L. E., & Whittaker, A. L. (2023). “Chemobrain” in childhood cancer survivors—the impact on social, academic, and daily living skills: a qualitative systematic review. Supportive Care in Cancer, 31(9), 15 pages.
2022 Semendric, I., Pollock, D., Haller, O., George, R., Collins-Praino, L., & Whittaker, A. (2022). ‘‘Chemobrain’’ in childhood cancer survivors — the impact on social, academic, and daily living skills: a qualitative systematic review protocol. JBI Evidence Synthesis, 20(1), 222-228.
Year Citation 2021 Haller, O., Whittaker, A., George, R., Semendric, I., & Collins-Praino, L. (2021). Investigating the effects of anti-inflammatory agents in pre-clinical models of chemotherapy-induced cognitive impairment – a systematic review protocol. PROSPERO- registration no: CRD42021240789. 2021 Semendric, I., Haller, O., George, R., Pollock, D., Whittaker, A., & Collins-Praino, L. (2021). Experience of the impact of chemobrain in childhood cancer survivors: a qualitative systematic review protocol. PROSPERO 2021 CRD42021240573. PROSPERO.
Laboratory Animal Science III (ANIML SC 3100RW)
Foundations of Human Neuroanatomy (ANAT SC 2006)
Essentials of Neuroscience (HLTH SC 1001)
Connect With Me